Patents Assigned to GE Healthcare AS
  • Patent number: 10413875
    Abstract: An arrangement for adding a first fluid component into a flow system, said arrangement comprising: a first pump provided in a first component adding fluid line which is connecting a first system fluid line of the flow system with a first fluid component source comprising the first fluid component to be added into the flow system; and a second pump provided in a second component adding fluid line connected in parallel with the first component adding fluid line, said second component adding fluid line connecting the first system fluid line of the flow system with a first fluid component source comprising the first fluid component to be added into the flow system.
    Type: Grant
    Filed: February 7, 2017
    Date of Patent: September 17, 2019
    Assignee: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Jan-Erik Pettersson Lynga, Asa Dahlstedt Hagman
  • Patent number: 10402508
    Abstract: The present invention relates to a diagnostic device (400) for measuring component performance on an automated radiopharmaceutical synthesis device (50).
    Type: Grant
    Filed: September 28, 2012
    Date of Patent: September 3, 2019
    Assignee: GE HEALTHCARE LIMITED
    Inventor: Robert F. Chisholm
  • Patent number: 10403411
    Abstract: The present invention relates to the field of radioactive substances and in particular to a method to facilitate handling of radioactive solutions. Provided by the present invention is a device that enables preparation of capsules filled with radioactivity. More particularly, the radioactivity is suitable for use in certain radiopharmaceutical procedures. The present invention provides improved accuracy and uniformity of patient doses. Furthermore, the potential for spills and needle stick injuries is reduced and the radiation burden is reduced.
    Type: Grant
    Filed: October 28, 2016
    Date of Patent: September 3, 2019
    Assignee: GE HEALTHCARE LIMITED
    Inventors: Nanno Schreuder, Gerard Swiers, Maikel Herbrink
  • Patent number: 10392651
    Abstract: A fluidic device is disclosed for processing a biological sample in order to extract nucleic acids contained in said sample and for subsequently amplifying said extracted nucleic acids, said device including a processed sample storage archive area 10 comprising an absorbent solid substrate 14 treated with at least one nucleic acid stabilizing reagent or reagent mix, said substrate allowing the generally dry and stabilized storage of said extracted and/or amplified nucleic acids, for example for long term storage of biological samples recovered forensically.
    Type: Grant
    Filed: February 20, 2015
    Date of Patent: August 27, 2019
    Assignee: GE Healthcare UK Limited
    Inventor: Nina Moran
  • Patent number: 10391422
    Abstract: A chromatography column having a longitudinal axis and comprising a column wall with a first end and a second end, a first end plate assembly removably connectable to said first end of the column wall, a second end plate assembly removably connectable to said second end of the column wall, wherein said first end plate assembly, said column wall and said second end plate assembly are arranged along the longitudinal axis of the column wherein the column wall, and/or first end plate assembly and/or second end plate assembly is/are rotatable about an axis of rotation wherein said axis of rotation is parallel to the longitudinal axis of said column and positioned outside the column.
    Type: Grant
    Filed: April 4, 2016
    Date of Patent: August 27, 2019
    Assignee: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Per Lofving, Mats Olsson, Sven Wounder, Jerker Persson
  • Patent number: 10393709
    Abstract: A holding system for holding and hoisting a chromatography column of one or more chromatography columns is disclosed. The holding system includes an upright member and a plurality of holding members movably arranged along the upright member. A first supporting member is positioned at an end portion of the chromatography column, wherein a holding member of the plurality of holding members is configured to be engaged to the first supporting member. A second supporting member is positioned at another end portion of the chromatography column. A holding member of the plurality of holding members is configured to be engaged to the second supporting member. One or more hoist assisting members may be also present. A hoist assisting member is operatively connected to the holding member engaged to the first supporting member. The hoist assisting member is operable to move the holding member connected to the first supporting member for hoisting the chromatography column.
    Type: Grant
    Filed: March 30, 2015
    Date of Patent: August 27, 2019
    Assignee: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Manoj Ramakrishna, Kishore Chengalvarayan, Nikhil Kamble
  • Publication number: 20190256812
    Abstract: A method for controlling at least one culture parameter in a bioreactor bag (1; 31a, 31b) provided in a bioreactor system, said method comprising the steps of: providing bioreactor information to a control unit (5; 35) controlling the bioreactor system; controlling the at least one culture parameter in dependence of the bioreactor information.
    Type: Application
    Filed: April 30, 2019
    Publication date: August 22, 2019
    Applicant: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Klaus Gebauer, Eva Lindskog, Lars Magnusson
  • Patent number: 10376813
    Abstract: The present invention relates to a method for the determination of chromatography conditions for the separation of a biomolecule from a liquid sample, which method comprises selecting a number of experiments using design of experiments (DoE); performing said experiments with in-line conditioning of orthogonal quality measures; and based on the results from the experiments, determining efficient chromatography conditions for said biomolecule. The invention also relates to a system for performing the method as well as a computer program and an instrument comprising such a computer program.
    Type: Grant
    Filed: June 3, 2016
    Date of Patent: August 13, 2019
    Assignee: GE HEALTHCARE BIO-SCIENCES AB
    Inventors: Enrique Napoleon Carredano, Gustav Jose Rodrigo
  • Publication number: 20190241608
    Abstract: The present invention relates to a method for removal of large contaminants, such as virus, in a chromatographic process for purification of a target molecule, preferably monoclonal antibodies, mAbs, by using a specifically designed chromatographic bead having a thin outer layer and a core functionalized with a ligand adsorbing the mAbs or parts thereof.
    Type: Application
    Filed: April 17, 2019
    Publication date: August 8, 2019
    Applicant: GE Healthcare BioProcess R&D AB
    Inventors: Jean-Luc Maloisel, Ola Lind, Bjorn Noren, Ronnie Palmgren
  • Patent number: 10372100
    Abstract: The present disclosure relates to a manufacturing system, method and control circuitry for quality assured manufacturing of at least two biopharmaceutical products. The manufacturing system comprises a warehouse facility, a hydration facility, and at least two biopharmaceutical manufacturing facilities, wherein the warehouse facility and hydration facility are comprised in the macro structure. Each biopharmaceutical manufacturing facility is comprised in a respective micro node, and a control facility in the macro structure is configured to control interoperability of the macro structure and the micro nodes by means of a network spine interconnecting the macro structure with each micro node.
    Type: Grant
    Filed: August 29, 2016
    Date of Patent: August 6, 2019
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Steve Robert Gravallese, Jason Naylor, Edwin Brian Taylor, Sven Frie, Patrick McMahon
  • Patent number: 10370649
    Abstract: The present invention relates to the field of nucleic acid collection and storage, and in particular to the collection and long-term storage of nuclei. The invention provides a device and method which can be used to capture and store nuclei at ambient temperatures allowing the subsequent isolation of nucleic acids by passive washing with a wash buffer. The present invention also provides a kit including the device of the invention suitable for carrying out the method of the invention.
    Type: Grant
    Filed: June 17, 2015
    Date of Patent: August 6, 2019
    Assignee: GE Healthcare UK Limited
    Inventors: Michael Kenneth Kenrick, Geraint Seymour
  • Patent number: 10371608
    Abstract: The invention discloses a cellulose or glass fiber paper for preservation of biological samples, which comprises 4-30 wt % of a hydrophilic branched carbohydrate polymer. It also discloses a method for preservation of biological samples by applying and drying them on the paper.
    Type: Grant
    Filed: October 29, 2012
    Date of Patent: August 6, 2019
    Assignee: GE Healthcare Bio-Sciences AB
    Inventors: Mattias Algotsson, Miles W. Burrows, Jimmy Hedin Dahlstrom, Ylva Laurin, Ronnie Palmgren, Jinyu Zou
  • Patent number: 10350314
    Abstract: A process for preparing a composition comprising encapsulated gas microbubbles, the process comprising: providing an aqueous protein solution of a heat-denaturable protein at a temperature necessary to achieve incipient denaturation; heating a gas by using heat from the heated protein solution; mixing the heated gas and the heated protein solution to obtain a gas/liquid mixture; and dispersing the gas into the protein solution by subjecting the gas/liquid mixture to mechanical shear forces to form a composition of gas microbubbles encapsulated by denatured protein.
    Type: Grant
    Filed: June 25, 2013
    Date of Patent: July 16, 2019
    Assignee: GE HEALTHCARE AS
    Inventors: Svein Kvaale, Ole Johannes Tokerud
  • Patent number: 10343142
    Abstract: The present invention relates to a chromatography ligand, which comprises Domain C from Staphylococcus protein A (SpA), or a functional fragment or variant thereof. The chromatography ligand presents an advantageous capability of withstanding harsh cleaning in place (CIP) conditions, and is capable of binding Fab fragments of antibodies. The ligand may be provided with a terminal coupling group, such as arginine or cysteine, to facilitate its coupling to an insoluble carrier such as beads or a membrane. The invention also relates process of using the ligand in isolation of antibodies, and to a purification protocol which may include washing steps and/or regeneration with alkali.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: July 9, 2019
    Assignee: GE HEALTHCARE BIOPROCESS R&D AB
    Inventors: Martin Hall, Sture Larsson, Andreas Muranyi, Gustav Rodrigo, Jinyu Zou, Per-Mikael Aberg
  • Patent number: D858264
    Type: Grant
    Filed: July 31, 2017
    Date of Patent: September 3, 2019
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Eric Tenander, Ethan Michael Barrieau, Ralph Stankowski
  • Patent number: D858265
    Type: Grant
    Filed: July 31, 2017
    Date of Patent: September 3, 2019
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Eric Tenander, Ethan Michael Barrieau, Ralph Stankowski
  • Patent number: D859136
    Type: Grant
    Filed: July 31, 2017
    Date of Patent: September 10, 2019
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Eric Tenander, Ethan Michael Barrieau, Ralph Stankowski
  • Patent number: D859137
    Type: Grant
    Filed: January 30, 2018
    Date of Patent: September 10, 2019
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Eric Tenander, Ethan Michael Barrieau, Ralph Stankowski
  • Patent number: D859970
    Type: Grant
    Filed: July 31, 2017
    Date of Patent: September 17, 2019
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Eric Tenander, Ethan Michael Barrieau, Ralph Stankowski
  • Patent number: D859971
    Type: Grant
    Filed: July 31, 2017
    Date of Patent: September 17, 2019
    Assignee: GE Healthcare Bio-Sciences Corp.
    Inventors: Eric Tenander, Ethan Michael Barrieau, Ralph Stankowski